Evidence map›Paper›PMID 34154700›Full record

ReviewBMB reports2021

Biomaterials-assisted spheroid engineering for regenerative therapy.

Na-Hyun Lee, Oyunchimeg Bayaraa, Zhou Zechu, Hye Sung Kim

Abstract readReview
In one paragraph

Review in BMB reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Optimizing Human Nasal Turbinate Stem Cell Dosage for the Effective Treatment of Empty Nose Syndrome.Journal of rhinology : official journal of the Korean Rhinologic Society · 2025
    Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. In Vitro Models for Peripheral Nerve Regeneration.Advanced healthcare materials · 2024
    Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Viscoelastic Biomaterials for Tissue Regeneration.Tissue engineering. Part C, Methods · 2022
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Na-Hyun LeeInstitute of Tissue Regeneration Engineering (ITREN), Dankook University, Cheonan 31116; Department of Nanobiomedical Science and BK21 NBM Global Research Center for Regenerative Medicine, Dankook University, Cheonan 31116, Korea.
Oyunchimeg BayaraaInstitute of Tissue Regeneration Engineering (ITREN), Dankook University, Cheonan 31116; Department of Nanobiomedical Science and BK21 NBM Global Research Center for Regenerative Medicine, Dankook University, Cheonan 31116, Korea.
Zhou ZechuInstitute of Tissue Regeneration Engineering (ITREN), Dankook University, Cheonan 31116; Department of Nanobiomedical Science and BK21 NBM Global Research Center for Regenerative Medicine, Dankook University, Cheonan 31116, Korea.
Hye Sung KimInstitute of Tissue Regeneration Engineering (ITREN), Dankook University, Cheonan 31116; Department of Regenerative Dental Medicine, College of Dentistry, Dankook University, Cheonan 31116, Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cell-based therapy is a promising approach in the field of regenerative medicine. As cells are formed into spheroids, their survival, functions, and engraftment in the transplanted site are significantly improved compared to single cell transplantation. To improve the therapeutic effect of cell spheroids even further, various biomaterials (e.g., nano- or microparticles, fibers, and hydrogels) have been developed for spheroid engineering. These biomaterials not only can control the overall spheroid formation (e.g., size, shape, aggregation speed, and degree of compaction), but also can regulate cell-to-cell and cell-to-matrix interactions in spheroids. Therefore, cell spheroids in synergy with biomaterials have recently emerged for cell-based regenerative therapy. Biomaterials-assisted spheroid engineering has been extensively studied for regeneration of bone or/and cartilage defects, critical limb ischemia, and myocardial infarction. Furthermore, it has been expanded to pancreas islets and hair follicle transplantation. This paper comprehensively reviews biomaterials-assisted spheroid engineering for regenerative therapy. [BMB Reports 2021; 54(7): 356-367].

Indexed as

AnimalsBiocompatible MaterialsBone RegenerationCell SurvivalGuided Tissue RegenerationHumansHydrogelsMesenchymal Stem CellsRegenerative MedicineSpheroids, CellularTissue EngineeringBiocompatible MaterialsHydrogels

Identifiers

PMID34154700
PMCPMC8328824

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.